<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0064">
 <label>64</label>
 <mixed-citation publication-type="journal" id="CIT0064-gen-2">(a) 
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Nocentini</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Alterio</surname>
    <given-names>V</given-names>
   </name>, 
   <name name-style="western">
    <surname>Bua</surname>
    <given-names>S</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Phenyl(thio)phosphon(amid)ate benzenesulfonamides as potent and selective inhibitors of human carbonic anhydrases II and VII counteract allodynia in a mouse model of oxaliplatin-induced neuropathy</article-title>. 
  <source>J Med Chem</source>
  <year>2020</year>;
  <volume>63</volume>:
  <fpage>5185</fpage>–
  <lpage>200</lpage>.
  <pub-id pub-id-type="pmid">32364386</pub-id>
 </mixed-citation>
 <mixed-citation publication-type="journal" id="CIT0064-gen-3">(b) 
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Supuran</surname>
    <given-names>CT.</given-names>
   </name>
  </person-group>
  <article-title>Carbonic anhydrases and metabolism</article-title>. 
  <source>Metabolites</source>
  <year>2018</year>;
  <volume>8</volume>:
  <fpage>25</fpage>. 
 </mixed-citation>
 <mixed-citation publication-type="journal" id="CIT0064-gen-4">(c) 
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Supuran</surname>
    <given-names>CT.</given-names>
   </name>
  </person-group>
  <article-title>Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas</article-title>. 
  <source>Expert Opin Ther Pat</source>
  <year>2018</year>;
  <volume>28</volume>:
  <fpage>709</fpage>–
  <lpage>12</lpage>. 
  <pub-id pub-id-type="pmid">30217119</pub-id>
 </mixed-citation>
 <mixed-citation publication-type="journal" id="CIT0064-gen-5">(d) 
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Supuran</surname>
    <given-names>CT.</given-names>
   </name>
  </person-group>
  <article-title>Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases</article-title>. 
  <source>Expert Opin Ther Pat</source>
  <year>2018</year>;
  <volume>28</volume>:
  <fpage>713</fpage>–
  <lpage>21</lpage>. 
  <pub-id pub-id-type="pmid">30175635</pub-id>
 </mixed-citation>
 <mixed-citation publication-type="journal" id="CIT0064-gen-6">(e) 
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Supuran</surname>
    <given-names>CT</given-names>
   </name>, 
   <name name-style="western">
    <surname>Altamimi</surname>
    <given-names>ASA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Carta</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013–2019</article-title>. 
  <source>Expert Opin Ther Pat</source>
  <year>2019</year>;
  <volume>29</volume>:
  <fpage>781</fpage>–
  <lpage>92</lpage>.
  <pub-id pub-id-type="pmid">31596641</pub-id>
 </mixed-citation>
</ref>
